// company-profile

Karyopharm Therapeutics Inc.

KPTI
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings143Insiders16
// api This Karyopharm Therapeutics Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

No insider transactions in the last 30 days.

// 90-day insight

Over the last 90 days, Karyopharm Therapeutics Inc. insiders bought $0 (12 transactions) and sold $39K (7 transactions).

  • Most active insider: Rangwala Reshma with 3 transactions totaling $8K.
  • Largest single sale: $21K by Paulson Richard A. on May 14, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Karyopharm Therapeutics Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$129.5M
QoQ change
+115.8%
Reporting period
2026-03-31
#1
Commodore Capital LP
CIK 1831942
$10.9M
1.9M shares
#2
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$10.7M
1.9M shares
#3
ADAGE CAPITAL PARTNERS GP, L.L.C.
CIK 1165408
$10.1M
1.8M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
May 21, 2026PAKIANATHAN DEEPIKAKPTI
Award
15,508$0.00$0K
May 21, 2026Su ZhenKPTI
Award
15,508$0.00$0K
May 21, 2026Greene Barry EKPTI
Award
15,508$0.00$0K
May 21, 2026Schor ChenKPTI
Award
15,508$0.00$0K
May 21, 2026BOHLIN GAREN GKPTI
Award
15,508$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.